X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8490) 8490
Book Review (3360) 3360
Publication (761) 761
Conference Proceeding (23) 23
Book Chapter (18) 18
Dissertation (3) 3
Magazine Article (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7184) 7184
humans (6746) 6746
oncology (5918) 5918
female (4037) 4037
chemotherapy (3862) 3862
cancer (3028) 3028
middle aged (2821) 2821
aged (2787) 2787
male (2465) 2465
antineoplastic combined chemotherapy protocols - therapeutic use (2348) 2348
adult (2213) 2213
treatment outcome (2005) 2005
care and treatment (1757) 1757
breast cancer (1538) 1538
antineoplastic agents - therapeutic use (1412) 1412
adjuvant chemotherapy (1349) 1349
survival (1317) 1317
metastasis (1312) 1312
prognosis (1290) 1290
breast neoplasms - drug therapy (1285) 1285
neoplasm staging (1207) 1207
medicine & public health (1191) 1191
phase-iii trial (1189) 1189
chemotherapy, adjuvant (1182) 1182
therapy (1177) 1177
research (1141) 1141
disease-free survival (1116) 1116
surgery (1097) 1097
phase-ii trial (1095) 1095
aged, 80 and over (1069) 1069
hematology, oncology and palliative medicine (1058) 1058
1st-line treatment (988) 988
trial (979) 979
drug therapy (953) 953
randomized-trial (916) 916
pharmacology & pharmacy (910) 910
antineoplastic combined chemotherapy protocols - adverse effects (892) 892
trastuzumab (892) 892
clinical trials (890) 890
radiotherapy (889) 889
health aspects (885) 885
analysis (870) 870
colorectal cancer (868) 868
open-label (825) 825
bevacizumab (807) 807
breast neoplasms - pathology (807) 807
docetaxel (802) 802
retrospective studies (798) 798
survival analysis (778) 778
survival rate (776) 776
plus (768) 768
fluorouracil (761) 761
neoplasm metastasis (720) 720
deoxycytidine - analogs & derivatives (710) 710
combined modality therapy (703) 703
colorectal neoplasms - drug therapy (696) 696
capecitabine (668) 668
paclitaxel (660) 660
fluorouracil - administration & dosage (648) 648
cancer therapies (646) 646
cisplatin (646) 646
antineoplastic agents (623) 623
carcinoma (621) 621
tumors (621) 621
oxaliplatin (613) 613
lung neoplasms - drug therapy (607) 607
clinical trials as topic (597) 597
animals (593) 593
antimitotic agents (580) 580
patients (579) 579
phase-iii (576) 576
antineoplastic combined chemotherapy protocols - administration & dosage (564) 564
phase-ii (561) 561
combination (545) 545
colorectal neoplasms - pathology (543) 543
adjuvant treatment (542) 542
vinorelbine plus cisplatin (538) 538
radiation-therapy (537) 537
deoxycytidine - administration & dosage (526) 526
randomized controlled trials as topic (525) 525
carcinoma, non-small-cell lung - drug therapy (521) 521
risk factors (511) 511
double-blind (506) 506
neoadjuvant therapy (506) 506
cancer research (486) 486
follow-up studies (470) 470
growth-factor receptor (464) 464
metastatic colorectal-cancer (464) 464
oncology, experimental (464) 464
neoadjuvant chemotherapy (459) 459
kaplan-meier estimate (455) 455
cell lung-cancer (454) 454
antineoplastic agents - adverse effects (450) 450
5-fluorouracil (447) 447
gemcitabine (440) 440
cisplatin - administration & dosage (436) 436
patient outcomes (435) 435
leucovorin (432) 432
drug administration schedule (424) 424
development and progression (421) 421
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8333) 8333
French (89) 89
German (55) 55
Spanish (10) 10
Italian (5) 5
Korean (4) 4
Hungarian (2) 2
Polish (2) 2
Portuguese (2) 2
Czech (1) 1
Icelandic (1) 1
Japanese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, ISSN 1470-2045, 2012, Volume 13, Issue 10, pp. 1045 - 1054
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 3, pp. 236 - 244
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 1/2008, Volume 100, Issue 2, pp. 121 - 133
Background Docetaxel is more effective than doxorubicin for patients with advanced breast cancer. The Breast International Group 02-98 randomized trial tested... 
CANCER PATIENTS | 1ST-LINE TREATMENT | PHASE-II TRIAL | THERAPY | EPIRUBICIN | ONCOLOGY | DOXORUBICIN PLUS CYCLOPHOSPHAMIDE | METHOTREXATE | COMBINATION CHEMOTHERAPY | FLUOROURACIL | CMF | Immunohistochemistry | Breast Neoplasms - surgery | Cyclophosphamide - administration & dosage | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Mastectomy - methods | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptors, Estrogen - analysis | Tamoxifen - administration & dosage | Receptors, Progesterone - analysis | Antineoplastic Agents, Phytogenic - administration & dosage | Breast Neoplasms - chemistry | Fluorouracil - administration & dosage | Adult | Female | Chemotherapy, Adjuvant | Odds Ratio | Adenocarcinoma - chemistry | Doxorubicin - administration & dosage | Drug Administration Schedule | Estrogen Receptor Modulators - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Lymphatic Metastasis | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Methotrexate - administration & dosage | Aged | Adenocarcinoma - surgery | Breast cancer | Dosage and administration | Drug therapy | Comparative analysis | Doxorubicin | Docetaxel | Clinical trials | Comparative studies | Chemotherapy | Index Medicus | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2004, Volume 350, Issue 17, pp. 1713 - 1721
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1245 - 1253
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 72, Issue 3, pp. 695 - 701
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9722, pp. 1267 - 1277
Journal Article